Engineered porcine cutaneous growth factor (rrhEGF) is receiving increased attention as a valuable strategy in the field of wound therapy. This bioactive compound, produced through molecular technology, delivers a https://recombinant-porcine-egf047296.zeeblogger.com/61588230/recombinant-swine-epidermal-growth-factor-a-effective-method-for-wound-repair